Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Move comes 2 years after controversial exit of brand-name product ...

Asthma remains one of the most prevalent chronic diseases in the US. 3 Although poor adherence substantially contributes to inadequate outcomes, even patients with high adherence often experience ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not ...

NEW YORK (CBSNewYork) – More than 24 million American have asthma and about 10 percent have a hard time controlling it, despite treatment. As CBS2's Dr. Max Gomez reports, there's a new type of ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

Please provide your email address to receive an email when new articles are posted on . “Asthma care in the Netherlands is divided between different health care providers, including respiratory ...

What can you do to help your eosinophilic asthma treatments work their best? There are simple steps you can take each day to improve symptoms, quality of life, and overall health. Eosinophilic asthma ...